Drug Information
Drug Generic Name | METHYLDOPA |
Drug Class | CENTRAL ANTIHYPERTENSIVE DRUGS |
Chapter | Cardiovascular System |
This is a centrally acting anti-hypertensive drug. Indications: moderate to severe hypertension in conjunction with a diuretic; pregnancy-induced hypertension. Cautions: positive direct Coomb's test in 20% of patients; interference with laboratory tests; reduce initial dose in renal impairment; blood counts and liver function tests advised. Contra-indications: history of depression; liver disease, phaeochromocytoma, porphyria. Side Effects: gastrointestinal disturbances; dry mouth; stomatitis, sialdenitis, bradycardia, exacerbation of angina, postural hypotension, edema, sedation, depression, dizziness, myalgia, nightmares, abnormal liver function tests, hepatitis, jaundice, pancreatitis, haemolytic anemia, leucopenia, thrombocytopenia, eosinophilia, nasal congestion, sexual dysfunction, amenorrhea, hyperprolactinemia. Dose: by mouth, 250 mg 3 times daily gradually increased; max. dose 3 g daily; In elderly, 125 mg 2 times daily increased to max. of 2 gm daily. |
|
Brand Name |
|